Required CCSG Acknowledgement

The NCI requires that publications acknowledge the Hillman CCSG support, and they are tracking compliance. If a Hillman CCSG-supported Shared Resource provided data used in your publication, please include the following statement in the acknowledgment section of your publication(s):

"This project used the Hillman [insert name(s) of shared resource(s)] that [is/are] supported in part by award P30CA047904."

Shared Resource Directors: Please make sure to include this statement on all of your order forms, contracts, etc. as a reminder to your users to acknowledge the Hillman CCSG support.

Pharmacokinetic (PK) and pharmacodynamic (PD) activities are often pursued separately, yet each provides a complementary aspect of the processes involved in the interaction between drugs and targets. The CPPF is uniquely positioned to provide PK and PD capabilities to the research community in an integrated and coordinated fashion. The activities of the CPPF are well poised to bridge the divide between preclinical and clinical studies. The services provided by the CPPF leverage knowledge, insight, and pharmacokinetic and pharmacodynamic (PK/PD) analytical tools and expertise in order to optimally support preclinical and clinical projects.